Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Aug 22, 2023 3:31pm
241 Views
Post# 35600477

RE:Stock Psychology

RE:Stock PsychologySeeing the recovery the past few days on no new "news"
Other than the revised investor presentation, brings abou some questions.
Seeing the very large volume, berings other questions.
We know there is/was a high short volume the past few weeks.
Could be as simple as a good old short squeeze.
Hoever, I hear there are some decent volume blocks.
Meaning larger scale investors.
We we do know the offering a month ago, was with an "institutional investor"
They dont usually loose $$$ . they are now above their "buy price" . Not yet at their warrents price.
Lots of room to grow.
Assuming the up-coming 90days reaches the discussed "agreement" for phase 3, the upside is in multiples.
Not a few dimes here or there.
A phase 3 pharma is worth a lot more than what ONC is trading at.


<< Previous
Bullboard Posts
Next >>